A patient with an anterior STEMI has been initiated on dual antiplatelet therapy, intravenous nitroglycerin, and oxygen therapy. Which nursing intervention is most critical to monitor for potential complications during the initial treatment phase?

D) Monitor for hypotension and headache as side effects of nitroglycerin.

A) Monitor for signs of bleeding, especially gastrointestinal bleeding.

B) Assess for allergic reactions to clopidogrel.

C) Evaluate the patient's response to oxygen therapy by measuring oxygen saturation.

D) Monitor for hypotension and headache as side effects of nitroglycerin.

A patient diagnosed with an anterior STEMI is receiving dual antiplatelet therapy and intravenous nitroglycerin. Which nursing action is most critical to prioritize in the initial hours of care to prevent further myocardial injury?

C) Continuously monitor the patient's ECG for any signs of arrhythmias.

A) Monitor the patient's blood glucose levels closely.

B) Assess the patient's pain level and provide additional analgesia if needed.

C) Continuously monitor the patient's ECG for any signs of arrhythmias.

D) Educate the patient about lifestyle changes to prevent future cardiac events.

A patient who underwent a percutaneous coronary intervention (PCI) for an anterior STEMI is now showing signs of acute heart failure. Which of the following nursing interventions is most appropriate to address the patient's pulmonary congestion?

B) Position the patient in a high Fowler's position to promote lung expansion.

A) Encourage the patient to increase fluid intake to prevent dehydration.

B) Position the patient in a high Fowler's position to promote lung expansion.

C) Administer a beta-blocker as the first-line treatment for heart failure.

D) Educate the patient on the importance of a low-sodium diet to manage heart failure.

A patient who recently underwent a percutaneous coronary intervention (PCI) for anterior STEMI is exhibiting signs of acute heart failure, including dyspnea, orthopnea, crackles in lung bases, and jugular venous distention. The clinical team has initiated treatment with intravenous furosemide and an ACE inhibitor. Which nursing intervention should be prioritized to monitor for complications associated with the new treatment plan?

A) Monitor the patient's blood pressure closely for signs of hypotension.

B) Encourage the patient to increase fluid intake to prevent dehydration.

C) Assess the patient's pain level regularly to ensure comfort.

D) Instruct the patient to perform incentive spirometry every hour.

A patient in the coronary care unit is experiencing acute kidney injury after a recent PCI, with rising serum creatinine and reduced urine output. Which of the following nursing interventions should be prioritized to manage the patient's condition effectively?

C) Monitor daily weights and strict input/output to assess fluid status

A) Increase the dose of furosemide to promote diuresis

B) Restrict fluid intake to prevent fluid overload

C) Monitor daily weights and strict input/output to assess fluid status

D) Administer ACE inhibitors to manage blood pressure

A patient in the coronary care unit is experiencing renal impairment with increased serum creatinine and BUN levels post-percutaneous coronary intervention (PCI). Which of the following nursing interventions is most appropriate to prioritize in managing the patient's condition?

B) Strictly monitor the patient's fluid intake and output to maintain an optimal fluid balance.

A) Increase the dose of furosemide to enhance diuresis and reduce fluid overload.

B) Strictly monitor the patient's fluid intake and output to maintain an optimal fluid balance.

C) Discontinue all ACE inhibitors immediately to prevent further renal compromise.

D) Initiate a high-protein diet to support renal function and recovery.

A patient with heart failure has developed acute kidney injury (AKI) following aggressive diuresis post-PCI. The clinical team has adjusted the treatment plan to include a lower dose of diuretics and potential addition of a thiazide diuretic. What is the most appropriate nursing intervention to prioritize in this situation?

A) Monitor the patient's weight daily to assess fluid balance.

B) Encourage the patient to increase fluid intake to prevent dehydration.

C) Administer an increased dose of potassium supplements to prevent hypokalemia.

D) Restrict the patient's sodium intake to prevent fluid overload.

A patient with heart failure who recently underwent PCI is developing signs of acute kidney injury (AKI) despite adjusted diuretic therapy. Which nursing intervention is most appropriate to prevent further deterioration of renal function in this patient?

C) Monitor electrolyte levels and adjust diuretics to maintain balance

A) Administer additional loop diuretics to manage fluid overload

B) Encourage increased oral fluid intake to improve renal perfusion

C) Monitor electrolyte levels and adjust diuretics to maintain balance

D) Increase the dosage of cardiac medications to enhance perfusion

acute coronary syndrome - Nursing Case Study

Pathophysiology

• Primary mechanism: Plaque rupture in coronary arteries triggers platelet aggregation and thrombus formation, leading to partial or complete obstruction of blood flow to the heart muscle.

• Secondary mechanism: The resultant ischemia causes myocardial cells to switch to anaerobic metabolism, leading to lactic acid accumulation, cellular injury, and potential necrosis if blood flow is not restored.

• Key complication: Prolonged ischemia can result in myocardial infarction, characterized by irreversible cardiac tissue damage, impaired cardiac function, and potential development of heart failure or arrhythmias.

Patient Profile

Demographics:

55-year-old male, construction worker

History:

• Hypertension, hyperlipidemia, type 2 diabetes

• Metoprolol, Atorvastatin, Metformin

• No known drug allergies

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm

• Key symptoms: Shortness of breath, diaphoresis, nausea

• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths/min, oxygen saturation 92% on room air, temperature 37.5°C

Section 1

New Diagnostic Results:

Following the initial presentation, the patient underwent a series of diagnostic tests to confirm the presence and extent of acute coronary syndrome. An electrocardiogram (ECG) was performed, revealing ST-segment elevations in the anterior leads, suggestive of an anterior ST-elevation myocardial infarction (STEMI). This finding indicated significant ischemic injury to the heart muscle, aligning with the patient’s symptoms of severe chest pain and shortness of breath. Blood tests showed elevated cardiac biomarkers, with a troponin I level markedly increased at 5.6 ng/mL (normal <0.04 ng/mL), indicating myocardial cell damage. Additionally, a complete blood count and basic metabolic panel were within normal ranges, except for hyperglycemia with a blood glucose level of 220 mg/dL.

In light of these findings, the clinical team initiated immediate interventions to restore coronary blood flow and limit myocardial injury. The patient was started on dual antiplatelet therapy with aspirin and clopidogrel, along with intravenous nitroglycerin to alleviate chest pain and reduce cardiac workload. Oxygen therapy was administered to address hypoxia, and the patient was prepared for urgent percutaneous coronary intervention (PCI). The urgency of these interventions was underscored by the risk of further complications, such as heart failure or life-threatening arrhythmias, if ischemia was not promptly resolved.

These diagnostic results and subsequent treatment decisions highlighted the need for vigilant monitoring and timely action in managing acute coronary syndrome. The healthcare team was prepared to adjust the treatment plan based on the patient's response and any emerging complications, ensuring a proactive approach to care. The next phase of the patient's journey would focus on the efficacy of the interventions and the management of potential complications as the clinical picture continued to evolve.

Section 2

New Complications

Despite the initial aggressive treatment and successful percutaneous coronary intervention (PCI) which restored partial coronary blood flow, the patient began to exhibit signs of developing complications. Within the first 24 hours post-PCI, the patient experienced increasing dyspnea and a persistent cough, accompanied by orthopnea and paroxysmal nocturnal dyspnea. On physical examination, crackles were auscultated in both lung bases, and jugular venous distention was noted. These findings suggested the onset of heart failure, likely due to the significant myocardial injury from the anterior STEMI.

Vital signs revealed a blood pressure of 140/85 mmHg, heart rate of 110 beats per minute, respiratory rate of 24 breaths per minute, and an oxygen saturation of 90% on room air. The patient's worsening condition prompted further diagnostics, including a chest X-ray, which showed pulmonary congestion, supporting the diagnosis of acute heart failure. Additionally, a repeat echocardiogram revealed a left ventricular ejection fraction of 35%, indicating reduced cardiac function.

In response to these developments, the clinical team adjusted the treatment plan to include diuretics such as intravenous furosemide to manage fluid overload and ACE inhibitors to reduce afterload and improve cardiac output. The patient was closely monitored for electrolyte imbalances due to diuretic therapy and was provided supplemental oxygen to maintain adequate saturation levels. The evolving clinical scenario required ongoing assessment and adjustment of therapy to prevent further deterioration, emphasizing the need for comprehensive management and close monitoring in the days following the acute coronary event. This highlighted the interconnectedness of acute coronary syndrome and heart failure, serving as a reminder of the importance of timely and effective intervention.

Section 3

As the patient continued under close observation in the coronary care unit, further complications began to emerge. By the second day post-PCI, despite the administration of diuretics and ACE inhibitors, the patient started showing signs of renal impairment. Laboratory tests revealed an increase in serum creatinine levels from 1.0 mg/dL to 2.3 mg/dL, and blood urea nitrogen (BUN) levels rose to 35 mg/dL, indicating acute kidney injury likely precipitated by the combined effects of heart failure and diuretic therapy. The patient also exhibited reduced urine output, falling to less than 400 mL over 24 hours, confirming oliguria.

In response to the renal complications, the clinical team faced the challenge of balancing fluid management while avoiding further renal compromise. The furosemide dose was carefully adjusted, and nephrotoxic medications were reviewed and minimized. Additionally, the patient was placed on a strict fluid balance chart to precisely monitor input and output, ensuring adequate hydration without exacerbating fluid overload. The choice of ACE inhibitors was reassessed, considering the risk of worsening renal function, and alternative medications were discussed.

This new development required the team to adapt their management strategy, emphasizing the importance of a multidisciplinary approach. The nephrology team was consulted to provide expertise in managing the patient's renal function, while the cardiology team continued to focus on optimizing cardiac output and preventing further heart failure exacerbations. This situation underscored the complexity of managing acute coronary syndrome in the presence of evolving complications, highlighting the necessity for dynamic clinical reasoning and the integration of multiple specialties to ensure comprehensive care.

Section 4

By the third day post-PCI, the patient's condition presented further challenges as new complications emerged. The nursing team observed a change in the patient's respiratory status. The patient began experiencing increased shortness of breath and was noted to have a persistent cough, which raised concerns about potential pulmonary congestion secondary to heart failure exacerbation. Upon auscultation, bilateral crackles were present in the lower lung fields, indicating fluid accumulation. Vital signs showed a heart rate of 105 bpm, blood pressure of 110/70 mmHg, respiratory rate of 24 breaths per minute, and oxygen saturation of 90% on room air, necessitating supplemental oxygen therapy.

An urgent chest X-ray was ordered, revealing bilateral pulmonary edema, confirming the suspicion of fluid overload. The patient's lab results showed a further decrease in sodium levels to 130 mmol/L, consistent with dilutional hyponatremia, a common complication in patients with congestive heart failure. The team recognized the need to carefully manage fluid status while addressing the cardiac and renal concerns, understanding that the delicate balance between diuresis and renal protection was critical.

In response to these developments, the clinical team adjusted the treatment regimen. The diuretic therapy was optimized, and the patient was placed on a low-sodium diet to help manage fluid retention. The cardiology team reassessed the patient's cardiac medications, considering the addition of a beta-blocker to improve heart function and reduce heart rate, while nephrology continued to monitor renal parameters closely. This evolving situation required the team to exercise clinical reasoning, weighing the risks and benefits of each intervention, and reinforced the importance of a collaborative, multidisciplinary approach in managing the complexities of acute coronary syndrome with concurrent renal and cardiac complications.

Section 5

As the clinical team continued to monitor the patient, a new complication emerged on the fourth day post-PCI. Despite the optimization of diuretic therapy and dietary adjustments, the patient began to show signs of acute kidney injury (AKI), a potential consequence of aggressive diuresis combined with underlying cardiac issues. Laboratory results indicated a rising creatinine level of 2.1 mg/dL from a baseline of 1.1 mg/dL, and a blood urea nitrogen (BUN) level of 45 mg/dL. Urine output had decreased significantly to 20 mL/hour, suggesting impaired renal function. These findings prompted the nephrology team to reassess the balance between fluid removal and renal perfusion, highlighting the importance of renal protection in the context of heart failure management.

In response to these developments, the clinical team adjusted the treatment strategy once again. The diuretic regimen was modified to include a lower dose with the potential addition of a thiazide diuretic to help manage fluid overload without further compromising renal function. Fluid intake was carefully regulated, and the patient's electrolyte levels were closely monitored to prevent further hyponatremia or electrolyte imbalances. The cardiology team also considered the potential need to adjust cardiac medications to reduce the workload on the heart while ensuring adequate perfusion to the kidneys.

This situation underscored the necessity for continuous reassessment and interdisciplinary collaboration. The team needed to exercise clinical reasoning by evaluating the risks and benefits of each intervention, particularly in the context of the patient's cardiac and renal status. As the patient's condition evolved, the team remained vigilant for any signs of worsening function or new complications, prepared to adapt the care plan as necessary to ensure the best possible outcomes. The next phase of the patient's journey would depend on their response to these adjusted interventions, with the goal of stabilizing both cardiac and renal function.